Insider Trading Activity AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) – CEO Sold 20,000 shares of Stock

ME Staff

6 years ago

Insider Trading Activity For AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG)

William K Heiden , CEO of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) reportedly Sold 20,000 shares of the company’s stock at an average price of 25 for a total transaction amount of $500,000.00 SEC Form

Insider Trading History For AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG)

On 1/7/2014 Christopher White, Insider, sold 5,000 with an average share price of $23.90 per share and the total transaction amounting to $119,500.00.

On 1/9/2014 Christopher White, Insider, sold 4,000 with an average share price of $22.37 per share and the total transaction amounting to $89,480.00.

On 1/9/2015 Adage Capital Partners Gp Llc, Major Shareholder, sold 1,250,000 with an average share price of $46.49 per share and the total transaction amounting to $58,112,500.00.

On 6/3/2015 Scott A Holmes, SVP, sold 22,516 with an average share price of $68.88 per share and the total transaction amounting to $1,550,902.08.

On 6/4/2015 Frank E Thomas, COO, sold 20,000 with an average share price of $69.47 per share and the total transaction amounting to $1,389,400.00.

On 6/5/2015 William K Heiden, CEO, sold 66,875 with an average share price of $69.90 per share and the total transaction amounting to $4,674,562.50.

On 6/15/2015 Scott A Holmes, SVP, sold 7,580 with an average share price of $66.63 per share and the total transaction amounting to $505,055.40.

Analyst Ratings History For AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG)

On 1/9/2017 Raymond James Reiterated Rating Market Perform ➝ Underperform
On 1/11/2017 Needham & Company LLC Downgraded rating Buy ➝ Hold
On 1/31/2017 JPMorgan Chase & Co. Set Price Target of rating Hold with a price target of $24.00
On 2/2/2017 Guggenheim Lower Price Target of rating Buy with a price target of $42.00 ➝ $28.00
On 6/1/2017 Barclays Reiterated Rating Equal Weight with a price target of $25.00 ➝ $20.00
On 7/7/2017 Citigroup Lower Price Target of rating Hold with a price target of $24.00
On 8/31/2017 Deutsche Bank Reiterated Rating Hold with a price target of $24.00

Recent Trading Activity for AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG)
Shares of AMAG Pharmaceuticals, Inc. closed the previous trading session at 25.10 up +0.20 0.80% with 25.100000381469727 shares trading hands.